Losing weight is hard. Keeping it off is harder. But a new international analysis of 18 randomized controlled trials suggests that one of the most effective tools for long-term weight maintenance is also one of the simplest: walking about 8,500 steps a day.
The research, presented at the European Congress on Obesity in Istanbul in May 2026, pooled data from 3,758 participants across trials that combined dietary advice with step-counting goals. Led by Prof. Marwan El Ghoch and published separately in the International Journal of Environmental Research and Public Health, the systematic review and meta-analysis found that people in the intervention groups increased their daily walking from a pooled mean of roughly 7,280 steps at baseline to a pooled mean of about 8,454 steps by the end of the weight-loss phase. (The headline figure of 8,500 is a rounded approximation of that pooled mean; the study does not report confidence intervals for these estimates.) That gain of approximately 1,200 steps per day, the equivalent of 10 to 15 minutes of brisk walking, held through the transition into the maintenance phase, the period when most dieters start regaining.
“The key message is that step-based lifestyle programs are a feasible and effective strategy for weight maintenance, not just weight loss,” Prof. El Ghoch said in a statement accompanying the congress presentation. “What surprised us was how consistent the step increase was across very different trial designs and populations.”
The finding reframes a familiar frustration. Decades of research have shown that exercise alone is a poor weight-loss strategy. But physical activity plays a different and far more powerful role after the pounds come off. A March 2026 update to the Endotext expert reference series, in a chapter on behavioral approaches to obesity management authored by Suzanne Phelan and Rena R. Wing, reinforces this distinction: structured physical activity is not a reliable driver of initial weight loss, but it is one of the strongest predictors of whether that loss sticks. The 8,500-step target gives that principle a concrete, trackable number.
What the trials actually tested
Of the 18 randomized controlled trials included in the systematic review, 14 contributed data to the quantitative meta-analysis. Each trial tested a specific lifestyle intervention against a control condition, and the designs were rigorous: these were not observational surveys or self-reported questionnaires but controlled experiments with defined protocols and follow-up periods.
Several of the individual trials stand out. A gender-tailored RCT evaluated whether behavioral and physical-activity interventions could prevent weight regain in men over a follow-up period of up to three years, though the primary endpoint may have been assessed at an earlier time point with extended follow-up thereafter. Another tested a web-based program paired with an activity monitor, using real-time feedback on step counts to sustain maintenance-phase behavior. A UK-funded Health Technology Assessment trial targeting adults at high cardiovascular risk included full protocol details, intervention manuals, and process evaluations that go well beyond a standard journal article.
What these programs had in common was simplicity. They emphasized everyday movement over athletic training, used pedometers or app-based trackers to make progress visible, and built step goals into daily routines rather than gym schedules. That accessibility may be part of why the approach worked: participants could sustain it without special equipment, memberships, or athletic ability.
Where the evidence has limits
The strongest data covers the weight-loss phase and the early maintenance window. Only one contributing trial tracked participants for as long as three years, and none extended beyond that mark. Whether the 8,500-step target continues to protect against regain at five or ten years remains an open question.
The participant pool also skews narrow. Several of the included trials, such as the SHED-IT and EuroFIT programs, enrolled only men. The broader meta-analysis does not clearly report how well its sample represents women, older adults, non-Western populations, or people with mobility limitations. For readers outside those demographics, the 8,500-step figure is best understood as directional guidance, not a universal prescription.
There is also the question of why steps work better than other forms of exercise for maintenance. The analysis identifies a correlation between reaching roughly 8,500 daily steps and better outcomes, but it does not isolate the mechanism. Walking may succeed in part because it is easy to track, requires no learning curve, and fits into the gaps of a normal day. But that is an inference from the trial designs, not a tested hypothesis within the data itself.
How to put 8,500 steps into practice
For anyone who has recently finished a diet or weight-loss program, the first step is finding out how much you already walk. Most smartphones and fitness trackers record step counts automatically. Look at an average week to establish a realistic baseline rather than focusing on a single active or inactive day.
From there, the goal is not to jump straight to 8,500 but to close the gap gradually. Someone averaging 6,000 steps might aim for 6,500 to 7,000 over the next few weeks, then reassess. Small, consistent increases are more sustainable than ambitious jumps that fade after a few days.
Common strategies from the trials include getting off public transport one stop early, taking stairs instead of elevators, adding a short walk after meals, or scheduling walking phone calls. The programs consistently emphasized weaving movement into daily life rather than carving out separate exercise sessions.
Tracking appears to matter as much as the walking itself. Across the trials, participants who used pedometers, accelerometers, or app-based trackers and received regular feedback stayed more engaged with their targets, especially during the vulnerable post-diet window when motivation tends to drop. Seeing the numbers, it turns out, helps people stick with the habit.
Expectations should stay realistic. The evidence does not show that adding 1,200 steps will drive ongoing weight loss without dietary control. The benefit lies in reducing the likelihood and speed of regain. In practice, that means pairing a daily step routine with continued attention to portion sizes, food quality, and the behavioral strategies learned during the weight-loss phase.
Who should talk to a doctor first
Anyone with existing health conditions, joint problems, or a very low baseline activity level should discuss step targets with a healthcare professional before making large changes. For people with mobility limitations, the spirit of the evidence may matter more than the specific number: regular, trackable movement that can be sustained over months and years. The 8,500-step benchmark can serve as a reference point for building an individualized plan, not a rigid threshold that must be hit exactly.
The analysis also does not address whether the finding applies to people using GLP-1 receptor agonist medications such as semaglutide (sold as Wegovy and Ozempic) or tirzepatide (Mounjaro and Zepbound), which have become widely prescribed for weight management. Because these drugs alter appetite and metabolism through different pathways, the interaction between pharmacological weight loss and step-based maintenance is a question future research will need to answer. For now, the 8,500-step target is best supported for people who lost weight primarily through dietary and behavioral interventions, the population the trials actually studied.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
